Benoit Destenaves
Director
IMED Biotech Unit
Astra Zeneca
United Kingdom
Biography
Benoit specialises in the study of molecular biomarkers (DNA and RNA). He joined AstraZeneca's IMED Biotech unit in 2013 as Director, leading the Molecular Diagnostics labs and Pharmacogenomics. He heads a team of 14 scientists in charge of evaluation technology platforms for companion diagnostics, developing molecular diagnostics in partnership with diagnostic companies and supporting clinical testing. One of the key interests of his group is oncology, with a strong focus on novel approaches (e.g. ctDNA analysis, NGS).
Research Interest
pharmacogenomics
